TNF and tuberculosis: For this reason, exclusion of active tuberculosis (TB) and treatment of LTBI are, therefore, clinical imperatives prior to starting anti-TNF-α therapy and active surveillance for a history of untreated or partially treated TB or LTBI has already been shown to be effective in reducing the number of incident TB cases [12–14].